Global Inactivated Influenza Virus Vaccine Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global Inactivated Influenza Virus Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Inactivated Influenza Virus Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Inactivated Influenza Virus Vaccine market in any manner.
Global Inactivated Influenza Virus Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
CSL
GSK
Sanofi Pasteur
Mylan
AstraZeneca
Pfizer
Johnson & Johnson
Jiangsu Jindik Biotechnology Co., Ltd
Beijing Kexing Biological Products Co., Ltd
Jiangsu Kangrun Biotechnology Co., Ltd
Hualan Bio Vaccines Co., Ltd
Dalian Yalifeng Biopharmaceutical Co., Ltd
Shanghai Institute of Biological Products Co., Ltd
Changchun Institute of Biological Products Co., Ltd
Lanzhou Institute of Biological Products Co., Ltd
Zhejiang Tian Yuan Biopharmaceutical Co., Ltd
Emmi Chengxin Biopharmaceutical Co., Ltd
Market Segmentation (by Type)
Whole Virus Vaccine
Subunit Vaccine
Market Segmentation (by Application)
Hospital
Clinic
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Inactivated Influenza Virus Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global Inactivated Influenza Virus Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Inactivated Influenza Virus Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Inactivated Influenza Virus Vaccine market in any manner.
Global Inactivated Influenza Virus Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
CSL
GSK
Sanofi Pasteur
Mylan
AstraZeneca
Pfizer
Johnson & Johnson
Jiangsu Jindik Biotechnology Co., Ltd
Beijing Kexing Biological Products Co., Ltd
Jiangsu Kangrun Biotechnology Co., Ltd
Hualan Bio Vaccines Co., Ltd
Dalian Yalifeng Biopharmaceutical Co., Ltd
Shanghai Institute of Biological Products Co., Ltd
Changchun Institute of Biological Products Co., Ltd
Lanzhou Institute of Biological Products Co., Ltd
Zhejiang Tian Yuan Biopharmaceutical Co., Ltd
Emmi Chengxin Biopharmaceutical Co., Ltd
Market Segmentation (by Type)
Whole Virus Vaccine
Subunit Vaccine
Market Segmentation (by Application)
Hospital
Clinic
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Inactivated Influenza Virus Vaccine Market
- Overview of the regional outlook of the Inactivated Influenza Virus Vaccine Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Inactivated Influenza Virus Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Inactivated Influenza Virus Vaccine
1.2 Key Market Segments
1.2.1 Inactivated Influenza Virus Vaccine Segment by Type
1.2.2 Inactivated Influenza Virus Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INACTIVATED INFLUENZA VIRUS VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Inactivated Influenza Virus Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Inactivated Influenza Virus Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INACTIVATED INFLUENZA VIRUS VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Global Inactivated Influenza Virus Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Inactivated Influenza Virus Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Inactivated Influenza Virus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Inactivated Influenza Virus Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Inactivated Influenza Virus Vaccine Sales Sites, Area Served, Product Type
3.6 Inactivated Influenza Virus Vaccine Market Competitive Situation and Trends
3.6.1 Inactivated Influenza Virus Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Inactivated Influenza Virus Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 INACTIVATED INFLUENZA VIRUS VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Inactivated Influenza Virus Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INACTIVATED INFLUENZA VIRUS VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 INACTIVATED INFLUENZA VIRUS VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Inactivated Influenza Virus Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Inactivated Influenza Virus Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Inactivated Influenza Virus Vaccine Price by Type (2019-2024)
7 INACTIVATED INFLUENZA VIRUS VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Inactivated Influenza Virus Vaccine Market Sales by Application (2019-2024)
7.3 Global Inactivated Influenza Virus Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Inactivated Influenza Virus Vaccine Sales Growth Rate by Application (2019-2024)
8 INACTIVATED INFLUENZA VIRUS VACCINE MARKET SEGMENTATION BY REGION
8.1 Global Inactivated Influenza Virus Vaccine Sales by Region
8.1.1 Global Inactivated Influenza Virus Vaccine Sales by Region
8.1.2 Global Inactivated Influenza Virus Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Inactivated Influenza Virus Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Inactivated Influenza Virus Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Inactivated Influenza Virus Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Inactivated Influenza Virus Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Inactivated Influenza Virus Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 CSL
9.1.1 CSL Inactivated Influenza Virus Vaccine Basic Information
9.1.2 CSL Inactivated Influenza Virus Vaccine Product Overview
9.1.3 CSL Inactivated Influenza Virus Vaccine Product Market Performance
9.1.4 CSL Business Overview
9.1.5 CSL Inactivated Influenza Virus Vaccine SWOT Analysis
9.1.6 CSL Recent Developments
9.2 GSK
9.2.1 GSK Inactivated Influenza Virus Vaccine Basic Information
9.2.2 GSK Inactivated Influenza Virus Vaccine Product Overview
9.2.3 GSK Inactivated Influenza Virus Vaccine Product Market Performance
9.2.4 GSK Business Overview
9.2.5 GSK Inactivated Influenza Virus Vaccine SWOT Analysis
9.2.6 GSK Recent Developments
9.3 Sanofi Pasteur
9.3.1 Sanofi Pasteur Inactivated Influenza Virus Vaccine Basic Information
9.3.2 Sanofi Pasteur Inactivated Influenza Virus Vaccine Product Overview
9.3.3 Sanofi Pasteur Inactivated Influenza Virus Vaccine Product Market Performance
9.3.4 Sanofi Pasteur Inactivated Influenza Virus Vaccine SWOT Analysis
9.3.5 Sanofi Pasteur Business Overview
9.3.6 Sanofi Pasteur Recent Developments
9.4 Mylan
9.4.1 Mylan Inactivated Influenza Virus Vaccine Basic Information
9.4.2 Mylan Inactivated Influenza Virus Vaccine Product Overview
9.4.3 Mylan Inactivated Influenza Virus Vaccine Product Market Performance
9.4.4 Mylan Business Overview
9.4.5 Mylan Recent Developments
9.5 AstraZeneca
9.5.1 AstraZeneca Inactivated Influenza Virus Vaccine Basic Information
9.5.2 AstraZeneca Inactivated Influenza Virus Vaccine Product Overview
9.5.3 AstraZeneca Inactivated Influenza Virus Vaccine Product Market Performance
9.5.4 AstraZeneca Business Overview
9.5.5 AstraZeneca Recent Developments
9.6 Pfizer
9.6.1 Pfizer Inactivated Influenza Virus Vaccine Basic Information
9.6.2 Pfizer Inactivated Influenza Virus Vaccine Product Overview
9.6.3 Pfizer Inactivated Influenza Virus Vaccine Product Market Performance
9.6.4 Pfizer Business Overview
9.6.5 Pfizer Recent Developments
9.7 Johnson and Johnson
9.7.1 Johnson and Johnson Inactivated Influenza Virus Vaccine Basic Information
9.7.2 Johnson and Johnson Inactivated Influenza Virus Vaccine Product Overview
9.7.3 Johnson and Johnson Inactivated Influenza Virus Vaccine Product Market Performance
9.7.4 Johnson and Johnson Business Overview
9.7.5 Johnson and Johnson Recent Developments
9.8 Jiangsu Jindik Biotechnology Co., Ltd
9.8.1 Jiangsu Jindik Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Basic Information
9.8.2 Jiangsu Jindik Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Product Overview
9.8.3 Jiangsu Jindik Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Product Market Performance
9.8.4 Jiangsu Jindik Biotechnology Co., Ltd Business Overview
9.8.5 Jiangsu Jindik Biotechnology Co., Ltd Recent Developments
9.9 Beijing Kexing Biological Products Co., Ltd
9.9.1 Beijing Kexing Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Basic Information
9.9.2 Beijing Kexing Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product Overview
9.9.3 Beijing Kexing Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product Market Performance
9.9.4 Beijing Kexing Biological Products Co., Ltd Business Overview
9.9.5 Beijing Kexing Biological Products Co., Ltd Recent Developments
9.10 Jiangsu Kangrun Biotechnology Co., Ltd
9.10.1 Jiangsu Kangrun Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Basic Information
9.10.2 Jiangsu Kangrun Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Product Overview
9.10.3 Jiangsu Kangrun Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Product Market Performance
9.10.4 Jiangsu Kangrun Biotechnology Co., Ltd Business Overview
9.10.5 Jiangsu Kangrun Biotechnology Co., Ltd Recent Developments
9.11 Hualan Bio Vaccines Co., Ltd
9.11.1 Hualan Bio Vaccines Co., Ltd Inactivated Influenza Virus Vaccine Basic Information
9.11.2 Hualan Bio Vaccines Co., Ltd Inactivated Influenza Virus Vaccine Product Overview
9.11.3 Hualan Bio Vaccines Co., Ltd Inactivated Influenza Virus Vaccine Product Market Performance
9.11.4 Hualan Bio Vaccines Co., Ltd Business Overview
9.11.5 Hualan Bio Vaccines Co., Ltd Recent Developments
9.12 Dalian Yalifeng Biopharmaceutical Co., Ltd
9.12.1 Dalian Yalifeng Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Basic Information
9.12.2 Dalian Yalifeng Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Product Overview
9.12.3 Dalian Yalifeng Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Product Market Performance
9.12.4 Dalian Yalifeng Biopharmaceutical Co., Ltd Business Overview
9.12.5 Dalian Yalifeng Biopharmaceutical Co., Ltd Recent Developments
9.13 Shanghai Institute of Biological Products Co., Ltd
9.13.1 Shanghai Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Basic Information
9.13.2 Shanghai Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product Overview
9.13.3 Shanghai Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product Market Performance
9.13.4 Shanghai Institute of Biological Products Co., Ltd Business Overview
9.13.5 Shanghai Institute of Biological Products Co., Ltd Recent Developments
9.14 Changchun Institute of Biological Products Co., Ltd
9.14.1 Changchun Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Basic Information
9.14.2 Changchun Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product Overview
9.14.3 Changchun Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product Market Performance
9.14.4 Changchun Institute of Biological Products Co., Ltd Business Overview
9.14.5 Changchun Institute of Biological Products Co., Ltd Recent Developments
9.15 Lanzhou Institute of Biological Products Co., Ltd
9.15.1 Lanzhou Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Basic Information
9.15.2 Lanzhou Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product Overview
9.15.3 Lanzhou Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product Market Performance
9.15.4 Lanzhou Institute of Biological Products Co., Ltd Business Overview
9.15.5 Lanzhou Institute of Biological Products Co., Ltd Recent Developments
9.16 Zhejiang Tian Yuan Biopharmaceutical Co., Ltd
9.16.1 Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Basic Information
9.16.2 Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Product Overview
9.16.3 Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Product Market Performance
9.16.4 Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Business Overview
9.16.5 Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Recent Developments
9.17 Emmi Chengxin Biopharmaceutical Co., Ltd
9.17.1 Emmi Chengxin Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Basic Information
9.17.2 Emmi Chengxin Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Product Overview
9.17.3 Emmi Chengxin Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Product Market Performance
9.17.4 Emmi Chengxin Biopharmaceutical Co., Ltd Business Overview
9.17.5 Emmi Chengxin Biopharmaceutical Co., Ltd Recent Developments
10 INACTIVATED INFLUENZA VIRUS VACCINE MARKET FORECAST BY REGION
10.1 Global Inactivated Influenza Virus Vaccine Market Size Forecast
10.2 Global Inactivated Influenza Virus Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Inactivated Influenza Virus Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Inactivated Influenza Virus Vaccine Market Size Forecast by Region
10.2.4 South America Inactivated Influenza Virus Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Inactivated Influenza Virus Vaccine by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Inactivated Influenza Virus Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Inactivated Influenza Virus Vaccine by Type (2025-2030)
11.1.2 Global Inactivated Influenza Virus Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Inactivated Influenza Virus Vaccine by Type (2025-2030)
11.2 Global Inactivated Influenza Virus Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global Inactivated Influenza Virus Vaccine Sales (Kilotons) Forecast by Application
11.2.2 Global Inactivated Influenza Virus Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Inactivated Influenza Virus Vaccine
1.2 Key Market Segments
1.2.1 Inactivated Influenza Virus Vaccine Segment by Type
1.2.2 Inactivated Influenza Virus Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INACTIVATED INFLUENZA VIRUS VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Inactivated Influenza Virus Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Inactivated Influenza Virus Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INACTIVATED INFLUENZA VIRUS VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Global Inactivated Influenza Virus Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Inactivated Influenza Virus Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Inactivated Influenza Virus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Inactivated Influenza Virus Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Inactivated Influenza Virus Vaccine Sales Sites, Area Served, Product Type
3.6 Inactivated Influenza Virus Vaccine Market Competitive Situation and Trends
3.6.1 Inactivated Influenza Virus Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Inactivated Influenza Virus Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 INACTIVATED INFLUENZA VIRUS VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Inactivated Influenza Virus Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INACTIVATED INFLUENZA VIRUS VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 INACTIVATED INFLUENZA VIRUS VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Inactivated Influenza Virus Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Inactivated Influenza Virus Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Inactivated Influenza Virus Vaccine Price by Type (2019-2024)
7 INACTIVATED INFLUENZA VIRUS VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Inactivated Influenza Virus Vaccine Market Sales by Application (2019-2024)
7.3 Global Inactivated Influenza Virus Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Inactivated Influenza Virus Vaccine Sales Growth Rate by Application (2019-2024)
8 INACTIVATED INFLUENZA VIRUS VACCINE MARKET SEGMENTATION BY REGION
8.1 Global Inactivated Influenza Virus Vaccine Sales by Region
8.1.1 Global Inactivated Influenza Virus Vaccine Sales by Region
8.1.2 Global Inactivated Influenza Virus Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Inactivated Influenza Virus Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Inactivated Influenza Virus Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Inactivated Influenza Virus Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Inactivated Influenza Virus Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Inactivated Influenza Virus Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 CSL
9.1.1 CSL Inactivated Influenza Virus Vaccine Basic Information
9.1.2 CSL Inactivated Influenza Virus Vaccine Product Overview
9.1.3 CSL Inactivated Influenza Virus Vaccine Product Market Performance
9.1.4 CSL Business Overview
9.1.5 CSL Inactivated Influenza Virus Vaccine SWOT Analysis
9.1.6 CSL Recent Developments
9.2 GSK
9.2.1 GSK Inactivated Influenza Virus Vaccine Basic Information
9.2.2 GSK Inactivated Influenza Virus Vaccine Product Overview
9.2.3 GSK Inactivated Influenza Virus Vaccine Product Market Performance
9.2.4 GSK Business Overview
9.2.5 GSK Inactivated Influenza Virus Vaccine SWOT Analysis
9.2.6 GSK Recent Developments
9.3 Sanofi Pasteur
9.3.1 Sanofi Pasteur Inactivated Influenza Virus Vaccine Basic Information
9.3.2 Sanofi Pasteur Inactivated Influenza Virus Vaccine Product Overview
9.3.3 Sanofi Pasteur Inactivated Influenza Virus Vaccine Product Market Performance
9.3.4 Sanofi Pasteur Inactivated Influenza Virus Vaccine SWOT Analysis
9.3.5 Sanofi Pasteur Business Overview
9.3.6 Sanofi Pasteur Recent Developments
9.4 Mylan
9.4.1 Mylan Inactivated Influenza Virus Vaccine Basic Information
9.4.2 Mylan Inactivated Influenza Virus Vaccine Product Overview
9.4.3 Mylan Inactivated Influenza Virus Vaccine Product Market Performance
9.4.4 Mylan Business Overview
9.4.5 Mylan Recent Developments
9.5 AstraZeneca
9.5.1 AstraZeneca Inactivated Influenza Virus Vaccine Basic Information
9.5.2 AstraZeneca Inactivated Influenza Virus Vaccine Product Overview
9.5.3 AstraZeneca Inactivated Influenza Virus Vaccine Product Market Performance
9.5.4 AstraZeneca Business Overview
9.5.5 AstraZeneca Recent Developments
9.6 Pfizer
9.6.1 Pfizer Inactivated Influenza Virus Vaccine Basic Information
9.6.2 Pfizer Inactivated Influenza Virus Vaccine Product Overview
9.6.3 Pfizer Inactivated Influenza Virus Vaccine Product Market Performance
9.6.4 Pfizer Business Overview
9.6.5 Pfizer Recent Developments
9.7 Johnson and Johnson
9.7.1 Johnson and Johnson Inactivated Influenza Virus Vaccine Basic Information
9.7.2 Johnson and Johnson Inactivated Influenza Virus Vaccine Product Overview
9.7.3 Johnson and Johnson Inactivated Influenza Virus Vaccine Product Market Performance
9.7.4 Johnson and Johnson Business Overview
9.7.5 Johnson and Johnson Recent Developments
9.8 Jiangsu Jindik Biotechnology Co., Ltd
9.8.1 Jiangsu Jindik Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Basic Information
9.8.2 Jiangsu Jindik Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Product Overview
9.8.3 Jiangsu Jindik Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Product Market Performance
9.8.4 Jiangsu Jindik Biotechnology Co., Ltd Business Overview
9.8.5 Jiangsu Jindik Biotechnology Co., Ltd Recent Developments
9.9 Beijing Kexing Biological Products Co., Ltd
9.9.1 Beijing Kexing Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Basic Information
9.9.2 Beijing Kexing Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product Overview
9.9.3 Beijing Kexing Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product Market Performance
9.9.4 Beijing Kexing Biological Products Co., Ltd Business Overview
9.9.5 Beijing Kexing Biological Products Co., Ltd Recent Developments
9.10 Jiangsu Kangrun Biotechnology Co., Ltd
9.10.1 Jiangsu Kangrun Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Basic Information
9.10.2 Jiangsu Kangrun Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Product Overview
9.10.3 Jiangsu Kangrun Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Product Market Performance
9.10.4 Jiangsu Kangrun Biotechnology Co., Ltd Business Overview
9.10.5 Jiangsu Kangrun Biotechnology Co., Ltd Recent Developments
9.11 Hualan Bio Vaccines Co., Ltd
9.11.1 Hualan Bio Vaccines Co., Ltd Inactivated Influenza Virus Vaccine Basic Information
9.11.2 Hualan Bio Vaccines Co., Ltd Inactivated Influenza Virus Vaccine Product Overview
9.11.3 Hualan Bio Vaccines Co., Ltd Inactivated Influenza Virus Vaccine Product Market Performance
9.11.4 Hualan Bio Vaccines Co., Ltd Business Overview
9.11.5 Hualan Bio Vaccines Co., Ltd Recent Developments
9.12 Dalian Yalifeng Biopharmaceutical Co., Ltd
9.12.1 Dalian Yalifeng Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Basic Information
9.12.2 Dalian Yalifeng Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Product Overview
9.12.3 Dalian Yalifeng Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Product Market Performance
9.12.4 Dalian Yalifeng Biopharmaceutical Co., Ltd Business Overview
9.12.5 Dalian Yalifeng Biopharmaceutical Co., Ltd Recent Developments
9.13 Shanghai Institute of Biological Products Co., Ltd
9.13.1 Shanghai Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Basic Information
9.13.2 Shanghai Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product Overview
9.13.3 Shanghai Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product Market Performance
9.13.4 Shanghai Institute of Biological Products Co., Ltd Business Overview
9.13.5 Shanghai Institute of Biological Products Co., Ltd Recent Developments
9.14 Changchun Institute of Biological Products Co., Ltd
9.14.1 Changchun Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Basic Information
9.14.2 Changchun Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product Overview
9.14.3 Changchun Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product Market Performance
9.14.4 Changchun Institute of Biological Products Co., Ltd Business Overview
9.14.5 Changchun Institute of Biological Products Co., Ltd Recent Developments
9.15 Lanzhou Institute of Biological Products Co., Ltd
9.15.1 Lanzhou Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Basic Information
9.15.2 Lanzhou Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product Overview
9.15.3 Lanzhou Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product Market Performance
9.15.4 Lanzhou Institute of Biological Products Co., Ltd Business Overview
9.15.5 Lanzhou Institute of Biological Products Co., Ltd Recent Developments
9.16 Zhejiang Tian Yuan Biopharmaceutical Co., Ltd
9.16.1 Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Basic Information
9.16.2 Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Product Overview
9.16.3 Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Product Market Performance
9.16.4 Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Business Overview
9.16.5 Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Recent Developments
9.17 Emmi Chengxin Biopharmaceutical Co., Ltd
9.17.1 Emmi Chengxin Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Basic Information
9.17.2 Emmi Chengxin Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Product Overview
9.17.3 Emmi Chengxin Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Product Market Performance
9.17.4 Emmi Chengxin Biopharmaceutical Co., Ltd Business Overview
9.17.5 Emmi Chengxin Biopharmaceutical Co., Ltd Recent Developments
10 INACTIVATED INFLUENZA VIRUS VACCINE MARKET FORECAST BY REGION
10.1 Global Inactivated Influenza Virus Vaccine Market Size Forecast
10.2 Global Inactivated Influenza Virus Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Inactivated Influenza Virus Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Inactivated Influenza Virus Vaccine Market Size Forecast by Region
10.2.4 South America Inactivated Influenza Virus Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Inactivated Influenza Virus Vaccine by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Inactivated Influenza Virus Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Inactivated Influenza Virus Vaccine by Type (2025-2030)
11.1.2 Global Inactivated Influenza Virus Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Inactivated Influenza Virus Vaccine by Type (2025-2030)
11.2 Global Inactivated Influenza Virus Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global Inactivated Influenza Virus Vaccine Sales (Kilotons) Forecast by Application
11.2.2 Global Inactivated Influenza Virus Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Inactivated Influenza Virus Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Inactivated Influenza Virus Vaccine Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Inactivated Influenza Virus Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Inactivated Influenza Virus Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Inactivated Influenza Virus Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Influenza Virus Vaccine as of 2022)
Table 10. Global Market Inactivated Influenza Virus Vaccine Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Inactivated Influenza Virus Vaccine Sales Sites and Area Served
Table 12. Manufacturers Inactivated Influenza Virus Vaccine Product Type
Table 13. Global Inactivated Influenza Virus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Inactivated Influenza Virus Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Inactivated Influenza Virus Vaccine Market Challenges
Table 22. Global Inactivated Influenza Virus Vaccine Sales by Type (Kilotons)
Table 23. Global Inactivated Influenza Virus Vaccine Market Size by Type (M USD)
Table 24. Global Inactivated Influenza Virus Vaccine Sales (Kilotons) by Type (2019-2024)
Table 25. Global Inactivated Influenza Virus Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global Inactivated Influenza Virus Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global Inactivated Influenza Virus Vaccine Market Size Share by Type (2019-2024)
Table 28. Global Inactivated Influenza Virus Vaccine Price (USD/Ton) by Type (2019-2024)
Table 29. Global Inactivated Influenza Virus Vaccine Sales (Kilotons) by Application
Table 30. Global Inactivated Influenza Virus Vaccine Market Size by Application
Table 31. Global Inactivated Influenza Virus Vaccine Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Inactivated Influenza Virus Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global Inactivated Influenza Virus Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global Inactivated Influenza Virus Vaccine Market Share by Application (2019-2024)
Table 35. Global Inactivated Influenza Virus Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global Inactivated Influenza Virus Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Inactivated Influenza Virus Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America Inactivated Influenza Virus Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Inactivated Influenza Virus Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Inactivated Influenza Virus Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Inactivated Influenza Virus Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Inactivated Influenza Virus Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 43. CSL Inactivated Influenza Virus Vaccine Basic Information
Table 44. CSL Inactivated Influenza Virus Vaccine Product Overview
Table 45. CSL Inactivated Influenza Virus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. CSL Business Overview
Table 47. CSL Inactivated Influenza Virus Vaccine SWOT Analysis
Table 48. CSL Recent Developments
Table 49. GSK Inactivated Influenza Virus Vaccine Basic Information
Table 50. GSK Inactivated Influenza Virus Vaccine Product Overview
Table 51. GSK Inactivated Influenza Virus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. GSK Business Overview
Table 53. GSK Inactivated Influenza Virus Vaccine SWOT Analysis
Table 54. GSK Recent Developments
Table 55. Sanofi Pasteur Inactivated Influenza Virus Vaccine Basic Information
Table 56. Sanofi Pasteur Inactivated Influenza Virus Vaccine Product Overview
Table 57. Sanofi Pasteur Inactivated Influenza Virus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Sanofi Pasteur Inactivated Influenza Virus Vaccine SWOT Analysis
Table 59. Sanofi Pasteur Business Overview
Table 60. Sanofi Pasteur Recent Developments
Table 61. Mylan Inactivated Influenza Virus Vaccine Basic Information
Table 62. Mylan Inactivated Influenza Virus Vaccine Product Overview
Table 63. Mylan Inactivated Influenza Virus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Mylan Business Overview
Table 65. Mylan Recent Developments
Table 66. AstraZeneca Inactivated Influenza Virus Vaccine Basic Information
Table 67. AstraZeneca Inactivated Influenza Virus Vaccine Product Overview
Table 68. AstraZeneca Inactivated Influenza Virus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. AstraZeneca Business Overview
Table 70. AstraZeneca Recent Developments
Table 71. Pfizer Inactivated Influenza Virus Vaccine Basic Information
Table 72. Pfizer Inactivated Influenza Virus Vaccine Product Overview
Table 73. Pfizer Inactivated Influenza Virus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Pfizer Business Overview
Table 75. Pfizer Recent Developments
Table 76. Johnson and Johnson Inactivated Influenza Virus Vaccine Basic Information
Table 77. Johnson and Johnson Inactivated Influenza Virus Vaccine Product Overview
Table 78. Johnson and Johnson Inactivated Influenza Virus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Johnson and Johnson Business Overview
Table 80. Johnson and Johnson Recent Developments
Table 81. Jiangsu Jindik Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Basic Information
Table 82. Jiangsu Jindik Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Product Overview
Table 83. Jiangsu Jindik Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Jiangsu Jindik Biotechnology Co., Ltd Business Overview
Table 85. Jiangsu Jindik Biotechnology Co., Ltd Recent Developments
Table 86. Beijing Kexing Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Basic Information
Table 87. Beijing Kexing Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product Overview
Table 88. Beijing Kexing Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Beijing Kexing Biological Products Co., Ltd Business Overview
Table 90. Beijing Kexing Biological Products Co., Ltd Recent Developments
Table 91. Jiangsu Kangrun Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Basic Information
Table 92. Jiangsu Kangrun Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Product Overview
Table 93. Jiangsu Kangrun Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Jiangsu Kangrun Biotechnology Co., Ltd Business Overview
Table 95. Jiangsu Kangrun Biotechnology Co., Ltd Recent Developments
Table 96. Hualan Bio Vaccines Co., Ltd Inactivated Influenza Virus Vaccine Basic Information
Table 97. Hualan Bio Vaccines Co., Ltd Inactivated Influenza Virus Vaccine Product Overview
Table 98. Hualan Bio Vaccines Co., Ltd Inactivated Influenza Virus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Hualan Bio Vaccines Co., Ltd Business Overview
Table 100. Hualan Bio Vaccines Co., Ltd Recent Developments
Table 101. Dalian Yalifeng Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Basic Information
Table 102. Dalian Yalifeng Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Product Overview
Table 103. Dalian Yalifeng Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Dalian Yalifeng Biopharmaceutical Co., Ltd Business Overview
Table 105. Dalian Yalifeng Biopharmaceutical Co., Ltd Recent Developments
Table 106. Shanghai Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Basic Information
Table 107. Shanghai Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product Overview
Table 108. Shanghai Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Shanghai Institute of Biological Products Co., Ltd Business Overview
Table 110. Shanghai Institute of Biological Products Co., Ltd Recent Developments
Table 111. Changchun Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Basic Information
Table 112. Changchun Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product Overview
Table 113. Changchun Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Changchun Institute of Biological Products Co., Ltd Business Overview
Table 115. Changchun Institute of Biological Products Co., Ltd Recent Developments
Table 116. Lanzhou Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Basic Information
Table 117. Lanzhou Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product Overview
Table 118. Lanzhou Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Lanzhou Institute of Biological Products Co., Ltd Business Overview
Table 120. Lanzhou Institute of Biological Products Co., Ltd Recent Developments
Table 121. Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Basic Information
Table 122. Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Product Overview
Table 123. Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Business Overview
Table 125. Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Recent Developments
Table 126. Emmi Chengxin Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Basic Information
Table 127. Emmi Chengxin Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Product Overview
Table 128. Emmi Chengxin Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Emmi Chengxin Biopharmaceutical Co., Ltd Business Overview
Table 130. Emmi Chengxin Biopharmaceutical Co., Ltd Recent Developments
Table 131. Global Inactivated Influenza Virus Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 132. Global Inactivated Influenza Virus Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 133. North America Inactivated Influenza Virus Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 134. North America Inactivated Influenza Virus Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 135. Europe Inactivated Influenza Virus Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 136. Europe Inactivated Influenza Virus Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 137. Asia Pacific Inactivated Influenza Virus Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 138. Asia Pacific Inactivated Influenza Virus Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 139. South America Inactivated Influenza Virus Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 140. South America Inactivated Influenza Virus Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 141. Middle East and Africa Inactivated Influenza Virus Vaccine Consumption Forecast by Country (2025-2030) & (Units)
Table 142. Middle East and Africa Inactivated Influenza Virus Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 143. Global Inactivated Influenza Virus Vaccine Sales Forecast by Type (2025-2030) & (Kilotons)
Table 144. Global Inactivated Influenza Virus Vaccine Market Size Forecast by Type (2025-2030) & (M USD)
Table 145. Global Inactivated Influenza Virus Vaccine Price Forecast by Type (2025-2030) & (USD/Ton)
Table 146. Global Inactivated Influenza Virus Vaccine Sales (Kilotons) Forecast by Application (2025-2030)
Table 147. Global Inactivated Influenza Virus Vaccine Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Inactivated Influenza Virus Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Inactivated Influenza Virus Vaccine Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Inactivated Influenza Virus Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Inactivated Influenza Virus Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Inactivated Influenza Virus Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Influenza Virus Vaccine as of 2022)
Table 10. Global Market Inactivated Influenza Virus Vaccine Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Inactivated Influenza Virus Vaccine Sales Sites and Area Served
Table 12. Manufacturers Inactivated Influenza Virus Vaccine Product Type
Table 13. Global Inactivated Influenza Virus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Inactivated Influenza Virus Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Inactivated Influenza Virus Vaccine Market Challenges
Table 22. Global Inactivated Influenza Virus Vaccine Sales by Type (Kilotons)
Table 23. Global Inactivated Influenza Virus Vaccine Market Size by Type (M USD)
Table 24. Global Inactivated Influenza Virus Vaccine Sales (Kilotons) by Type (2019-2024)
Table 25. Global Inactivated Influenza Virus Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global Inactivated Influenza Virus Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global Inactivated Influenza Virus Vaccine Market Size Share by Type (2019-2024)
Table 28. Global Inactivated Influenza Virus Vaccine Price (USD/Ton) by Type (2019-2024)
Table 29. Global Inactivated Influenza Virus Vaccine Sales (Kilotons) by Application
Table 30. Global Inactivated Influenza Virus Vaccine Market Size by Application
Table 31. Global Inactivated Influenza Virus Vaccine Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Inactivated Influenza Virus Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global Inactivated Influenza Virus Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global Inactivated Influenza Virus Vaccine Market Share by Application (2019-2024)
Table 35. Global Inactivated Influenza Virus Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global Inactivated Influenza Virus Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Inactivated Influenza Virus Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America Inactivated Influenza Virus Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Inactivated Influenza Virus Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Inactivated Influenza Virus Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Inactivated Influenza Virus Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Inactivated Influenza Virus Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 43. CSL Inactivated Influenza Virus Vaccine Basic Information
Table 44. CSL Inactivated Influenza Virus Vaccine Product Overview
Table 45. CSL Inactivated Influenza Virus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. CSL Business Overview
Table 47. CSL Inactivated Influenza Virus Vaccine SWOT Analysis
Table 48. CSL Recent Developments
Table 49. GSK Inactivated Influenza Virus Vaccine Basic Information
Table 50. GSK Inactivated Influenza Virus Vaccine Product Overview
Table 51. GSK Inactivated Influenza Virus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. GSK Business Overview
Table 53. GSK Inactivated Influenza Virus Vaccine SWOT Analysis
Table 54. GSK Recent Developments
Table 55. Sanofi Pasteur Inactivated Influenza Virus Vaccine Basic Information
Table 56. Sanofi Pasteur Inactivated Influenza Virus Vaccine Product Overview
Table 57. Sanofi Pasteur Inactivated Influenza Virus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Sanofi Pasteur Inactivated Influenza Virus Vaccine SWOT Analysis
Table 59. Sanofi Pasteur Business Overview
Table 60. Sanofi Pasteur Recent Developments
Table 61. Mylan Inactivated Influenza Virus Vaccine Basic Information
Table 62. Mylan Inactivated Influenza Virus Vaccine Product Overview
Table 63. Mylan Inactivated Influenza Virus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Mylan Business Overview
Table 65. Mylan Recent Developments
Table 66. AstraZeneca Inactivated Influenza Virus Vaccine Basic Information
Table 67. AstraZeneca Inactivated Influenza Virus Vaccine Product Overview
Table 68. AstraZeneca Inactivated Influenza Virus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. AstraZeneca Business Overview
Table 70. AstraZeneca Recent Developments
Table 71. Pfizer Inactivated Influenza Virus Vaccine Basic Information
Table 72. Pfizer Inactivated Influenza Virus Vaccine Product Overview
Table 73. Pfizer Inactivated Influenza Virus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Pfizer Business Overview
Table 75. Pfizer Recent Developments
Table 76. Johnson and Johnson Inactivated Influenza Virus Vaccine Basic Information
Table 77. Johnson and Johnson Inactivated Influenza Virus Vaccine Product Overview
Table 78. Johnson and Johnson Inactivated Influenza Virus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Johnson and Johnson Business Overview
Table 80. Johnson and Johnson Recent Developments
Table 81. Jiangsu Jindik Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Basic Information
Table 82. Jiangsu Jindik Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Product Overview
Table 83. Jiangsu Jindik Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Jiangsu Jindik Biotechnology Co., Ltd Business Overview
Table 85. Jiangsu Jindik Biotechnology Co., Ltd Recent Developments
Table 86. Beijing Kexing Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Basic Information
Table 87. Beijing Kexing Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product Overview
Table 88. Beijing Kexing Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Beijing Kexing Biological Products Co., Ltd Business Overview
Table 90. Beijing Kexing Biological Products Co., Ltd Recent Developments
Table 91. Jiangsu Kangrun Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Basic Information
Table 92. Jiangsu Kangrun Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Product Overview
Table 93. Jiangsu Kangrun Biotechnology Co., Ltd Inactivated Influenza Virus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Jiangsu Kangrun Biotechnology Co., Ltd Business Overview
Table 95. Jiangsu Kangrun Biotechnology Co., Ltd Recent Developments
Table 96. Hualan Bio Vaccines Co., Ltd Inactivated Influenza Virus Vaccine Basic Information
Table 97. Hualan Bio Vaccines Co., Ltd Inactivated Influenza Virus Vaccine Product Overview
Table 98. Hualan Bio Vaccines Co., Ltd Inactivated Influenza Virus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Hualan Bio Vaccines Co., Ltd Business Overview
Table 100. Hualan Bio Vaccines Co., Ltd Recent Developments
Table 101. Dalian Yalifeng Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Basic Information
Table 102. Dalian Yalifeng Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Product Overview
Table 103. Dalian Yalifeng Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Dalian Yalifeng Biopharmaceutical Co., Ltd Business Overview
Table 105. Dalian Yalifeng Biopharmaceutical Co., Ltd Recent Developments
Table 106. Shanghai Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Basic Information
Table 107. Shanghai Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product Overview
Table 108. Shanghai Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Shanghai Institute of Biological Products Co., Ltd Business Overview
Table 110. Shanghai Institute of Biological Products Co., Ltd Recent Developments
Table 111. Changchun Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Basic Information
Table 112. Changchun Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product Overview
Table 113. Changchun Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Changchun Institute of Biological Products Co., Ltd Business Overview
Table 115. Changchun Institute of Biological Products Co., Ltd Recent Developments
Table 116. Lanzhou Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Basic Information
Table 117. Lanzhou Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Product Overview
Table 118. Lanzhou Institute of Biological Products Co., Ltd Inactivated Influenza Virus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Lanzhou Institute of Biological Products Co., Ltd Business Overview
Table 120. Lanzhou Institute of Biological Products Co., Ltd Recent Developments
Table 121. Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Basic Information
Table 122. Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Product Overview
Table 123. Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Business Overview
Table 125. Zhejiang Tian Yuan Biopharmaceutical Co., Ltd Recent Developments
Table 126. Emmi Chengxin Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Basic Information
Table 127. Emmi Chengxin Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Product Overview
Table 128. Emmi Chengxin Biopharmaceutical Co., Ltd Inactivated Influenza Virus Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Emmi Chengxin Biopharmaceutical Co., Ltd Business Overview
Table 130. Emmi Chengxin Biopharmaceutical Co., Ltd Recent Developments
Table 131. Global Inactivated Influenza Virus Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 132. Global Inactivated Influenza Virus Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 133. North America Inactivated Influenza Virus Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 134. North America Inactivated Influenza Virus Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 135. Europe Inactivated Influenza Virus Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 136. Europe Inactivated Influenza Virus Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 137. Asia Pacific Inactivated Influenza Virus Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 138. Asia Pacific Inactivated Influenza Virus Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 139. South America Inactivated Influenza Virus Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 140. South America Inactivated Influenza Virus Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 141. Middle East and Africa Inactivated Influenza Virus Vaccine Consumption Forecast by Country (2025-2030) & (Units)
Table 142. Middle East and Africa Inactivated Influenza Virus Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 143. Global Inactivated Influenza Virus Vaccine Sales Forecast by Type (2025-2030) & (Kilotons)
Table 144. Global Inactivated Influenza Virus Vaccine Market Size Forecast by Type (2025-2030) & (M USD)
Table 145. Global Inactivated Influenza Virus Vaccine Price Forecast by Type (2025-2030) & (USD/Ton)
Table 146. Global Inactivated Influenza Virus Vaccine Sales (Kilotons) Forecast by Application (2025-2030)
Table 147. Global Inactivated Influenza Virus Vaccine Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Inactivated Influenza Virus Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Inactivated Influenza Virus Vaccine Market Size (M USD), 2019-2030
Figure 5. Global Inactivated Influenza Virus Vaccine Market Size (M USD) (2019-2030)
Figure 6. Global Inactivated Influenza Virus Vaccine Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Inactivated Influenza Virus Vaccine Market Size by Country (M USD)
Figure 11. Inactivated Influenza Virus Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Inactivated Influenza Virus Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Inactivated Influenza Virus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Inactivated Influenza Virus Vaccine Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Inactivated Influenza Virus Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Inactivated Influenza Virus Vaccine Market Share by Type
Figure 18. Sales Market Share of Inactivated Influenza Virus Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of Inactivated Influenza Virus Vaccine by Type in 2023
Figure 20. Market Size Share of Inactivated Influenza Virus Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of Inactivated Influenza Virus Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Inactivated Influenza Virus Vaccine Market Share by Application
Figure 24. Global Inactivated Influenza Virus Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global Inactivated Influenza Virus Vaccine Sales Market Share by Application in 2023
Figure 26. Global Inactivated Influenza Virus Vaccine Market Share by Application (2019-2024)
Figure 27. Global Inactivated Influenza Virus Vaccine Market Share by Application in 2023
Figure 28. Global Inactivated Influenza Virus Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Inactivated Influenza Virus Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America Inactivated Influenza Virus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Inactivated Influenza Virus Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Inactivated Influenza Virus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Inactivated Influenza Virus Vaccine Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Inactivated Influenza Virus Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Inactivated Influenza Virus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Inactivated Influenza Virus Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Inactivated Influenza Virus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Inactivated Influenza Virus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Inactivated Influenza Virus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Inactivated Influenza Virus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Inactivated Influenza Virus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Inactivated Influenza Virus Vaccine Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Inactivated Influenza Virus Vaccine Sales Market Share by Region in 2023
Figure 44. China Inactivated Influenza Virus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Inactivated Influenza Virus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Inactivated Influenza Virus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Inactivated Influenza Virus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Inactivated Influenza Virus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Inactivated Influenza Virus Vaccine Sales and Growth Rate (Kilotons)
Figure 50. South America Inactivated Influenza Virus Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Inactivated Influenza Virus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Inactivated Influenza Virus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Inactivated Influenza Virus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Inactivated Influenza Virus Vaccine Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Inactivated Influenza Virus Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Inactivated Influenza Virus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Inactivated Influenza Virus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Inactivated Influenza Virus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Inactivated Influenza Virus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Inactivated Influenza Virus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Inactivated Influenza Virus Vaccine Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Inactivated Influenza Virus Vaccine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Inactivated Influenza Virus Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Inactivated Influenza Virus Vaccine Market Share Forecast by Type (2025-2030)
Figure 65. Global Inactivated Influenza Virus Vaccine Sales Forecast by Application (2025-2030)
Figure 66. Global Inactivated Influenza Virus Vaccine Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Inactivated Influenza Virus Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Inactivated Influenza Virus Vaccine Market Size (M USD), 2019-2030
Figure 5. Global Inactivated Influenza Virus Vaccine Market Size (M USD) (2019-2030)
Figure 6. Global Inactivated Influenza Virus Vaccine Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Inactivated Influenza Virus Vaccine Market Size by Country (M USD)
Figure 11. Inactivated Influenza Virus Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Inactivated Influenza Virus Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Inactivated Influenza Virus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Inactivated Influenza Virus Vaccine Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Inactivated Influenza Virus Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Inactivated Influenza Virus Vaccine Market Share by Type
Figure 18. Sales Market Share of Inactivated Influenza Virus Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of Inactivated Influenza Virus Vaccine by Type in 2023
Figure 20. Market Size Share of Inactivated Influenza Virus Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of Inactivated Influenza Virus Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Inactivated Influenza Virus Vaccine Market Share by Application
Figure 24. Global Inactivated Influenza Virus Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global Inactivated Influenza Virus Vaccine Sales Market Share by Application in 2023
Figure 26. Global Inactivated Influenza Virus Vaccine Market Share by Application (2019-2024)
Figure 27. Global Inactivated Influenza Virus Vaccine Market Share by Application in 2023
Figure 28. Global Inactivated Influenza Virus Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Inactivated Influenza Virus Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America Inactivated Influenza Virus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Inactivated Influenza Virus Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Inactivated Influenza Virus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Inactivated Influenza Virus Vaccine Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Inactivated Influenza Virus Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Inactivated Influenza Virus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Inactivated Influenza Virus Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Inactivated Influenza Virus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Inactivated Influenza Virus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Inactivated Influenza Virus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Inactivated Influenza Virus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Inactivated Influenza Virus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Inactivated Influenza Virus Vaccine Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Inactivated Influenza Virus Vaccine Sales Market Share by Region in 2023
Figure 44. China Inactivated Influenza Virus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Inactivated Influenza Virus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Inactivated Influenza Virus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Inactivated Influenza Virus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Inactivated Influenza Virus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Inactivated Influenza Virus Vaccine Sales and Growth Rate (Kilotons)
Figure 50. South America Inactivated Influenza Virus Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Inactivated Influenza Virus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Inactivated Influenza Virus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Inactivated Influenza Virus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Inactivated Influenza Virus Vaccine Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Inactivated Influenza Virus Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Inactivated Influenza Virus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Inactivated Influenza Virus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Inactivated Influenza Virus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Inactivated Influenza Virus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Inactivated Influenza Virus Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Inactivated Influenza Virus Vaccine Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Inactivated Influenza Virus Vaccine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Inactivated Influenza Virus Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Inactivated Influenza Virus Vaccine Market Share Forecast by Type (2025-2030)
Figure 65. Global Inactivated Influenza Virus Vaccine Sales Forecast by Application (2025-2030)
Figure 66. Global Inactivated Influenza Virus Vaccine Market Share Forecast by Application (2025-2030)
